A dual tumor-targeted phage, containing both a tumor homing ligand (the tripeptide Arg-Gly-Asp) and GRP78 promoter, leverages tumor specificity of the bacteriophage with introduction of highly expressed GRP78 promoter within tumor cells. The gene discussed is HSPA5; the disease is neoplasm.